Under the terms of the agreement, Glenmark will be responsible for regulatory approvals and supply of RYALTRIS for the Canadian
market. Bausch Health, Canada will be responsible for the commercialization of RYALTRIS in the Canadian
market, following regulatory approval.Under the terms of the agreement, Glenmark will be responsible for regulatory approvals and supply of RYALTRIS for the Canadian
market. Bausch Health, Canada will be responsible for the commercialization of RYALTRIS in the Canadian
market, following regulatory approval.Read More